Taysha Gene Therapies (TSHA) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.93
-0.53
-0.14
0.26

Details

Expected EPS
-0.107273
Actual EPS
-0.1
Surprise EPS
0.01
Surprise Percent
+6.78%

Description

Taysha Gene Therapies (TSHA) has reported earnings of -0.1 per share for Q2 2024.

0 Comments

Share your thoughts